Impact of Long-Term Cannabidiol (CBD) Treatment on Mouse Kidney Transcriptome
- PMID: 39766907
- PMCID: PMC11675924
- DOI: 10.3390/genes15121640
Impact of Long-Term Cannabidiol (CBD) Treatment on Mouse Kidney Transcriptome
Abstract
Background: Cannabidiol, which is one of the main cannabinoids present in Cannabis sativa plants, has been shown to have therapeutic properties, including anti-inflammatory and antioxidant effects that may be useful for treatment of various kidney conditions.
Objectives: This article investigates the effect of long-term cannabidiol (CBD) treatment on changes in the renal transcriptome in a mouse model. The main hypothesis was that systematic CBD treatment would affect gene expression associated with those processes in the kidney.
Methods: The study was conducted on male C57BL/6J mice. Mice in the experimental groups received daily intraperitoneal injections of CBD at doses of 10 mg/kg or 20 mg/kg body weight (b.w.) for 28 days. After the experiment, kidney tissues were collected, RNA was isolated, and RNA-Seq sequencing was performed.
Results: The results show CBD's effects on changes in gene expression, including the regulation of genes related to circadian rhythm (e.g., Ciart, Nr1d1, Nr1d2, Per2, and Per3), glucocorticoid receptor function (e.g., Cyp1b1, Ddit4, Foxo3, Gjb2, and Pck1), lipid metabolism (e.g., Cyp2d22, Cyp2d9, Decr2 Hacl1, and Sphk1), and inflammatory response (e.g., Cxcr4 and Ccl28).
Conclusions: The obtained results suggest that CBD may be beneficial for therapeutic purposes in treating kidney disease, and its effects should be further analyzed in clinical trials.
Keywords: CBD; RNA-seq; cannabidiol; kidney; mouse model.
Conflict of interest statement
All authors declare that have no competing interests.
Figures
Similar articles
-
Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice.Int J Neuropsychopharmacol. 2014 Oct 31;18(5):pyu041. doi: 10.1093/ijnp/pyu041. Int J Neuropsychopharmacol. 2014. PMID: 25618402 Free PMC article.
-
Cannabidiol regulates behavioural alterations and gene expression changes induced by spontaneous cannabinoid withdrawal.Br J Pharmacol. 2018 Jul;175(13):2676-2688. doi: 10.1111/bph.14226. Epub 2018 May 3. Br J Pharmacol. 2018. PMID: 29624642 Free PMC article.
-
Cannabidiol Enhances Intestinal Cannabinoid Receptor Type 2 Receptor Expression and Activation Increasing Regulatory T Cells and Reduces Murine Acute Graft-versus-Host Disease without Interfering with the Graft-versus-Leukemia Response.J Pharmacol Exp Ther. 2021 May;377(2):273-283. doi: 10.1124/jpet.120.000479. Epub 2021 Mar 3. J Pharmacol Exp Ther. 2021. PMID: 33658314
-
Molecular Targets of Cannabidiol in Neurological Disorders.Neurotherapeutics. 2015 Oct;12(4):699-730. doi: 10.1007/s13311-015-0377-3. Neurotherapeutics. 2015. PMID: 26264914 Free PMC article. Review.
-
Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations.Cannabis Cannabinoid Res. 2023 Apr;8(2):254-269. doi: 10.1089/can.2022.0133. Epub 2022 Nov 22. Cannabis Cannabinoid Res. 2023. PMID: 36413346 Review.
Cited by
-
Large-Scale Profiling of Coding and Long Noncoding Transcriptomes in the Hippocampus of Mice Acutely Exposed to Vaporized CBD or THC.Int J Mol Sci. 2025 Jul 23;26(15):7106. doi: 10.3390/ijms26157106. Int J Mol Sci. 2025. PMID: 40806237 Free PMC article.
-
Cannabinoid Receptor 1 Regulates Zebrafish Renal Multiciliated Cell Development via cAMP Signaling.J Dev Biol. 2025 Jun 17;13(2):20. doi: 10.3390/jdb13020020. J Dev Biol. 2025. PMID: 40558673 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials